Monocyte or white blood cell counts and β2 microglobulin predict the durable efficacy of daratumumab with lenalidomide
https://pubmed.ncbi.nlm.nih.gov/36530751/
京都大学 島津 裕 Ther Adv Hematol.2022 Dec 13;13:20406207221142487.

Monocyte or white blood cell counts and β2 microglobulin predict the durable efficacy of daratumumab with lenalidomide
https://pubmed.ncbi.nlm.nih.gov/36530751/